| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
24,613 |
22,195 |
$1.88M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,936 |
7,587 |
$332K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,434 |
2,224 |
$274K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,166 |
1,129 |
$159K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
905 |
868 |
$111K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,341 |
2,250 |
$109K |
| 96127 |
|
3,125 |
2,963 |
$67K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
468 |
439 |
$56K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
611 |
556 |
$43K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,757 |
1,693 |
$42K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,300 |
1,238 |
$37K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
940 |
893 |
$28K |
| 92558 |
|
1,124 |
1,082 |
$26K |
| 99173 |
|
3,605 |
3,438 |
$25K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
170 |
156 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
147 |
142 |
$7K |
| 99051 |
|
794 |
753 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
203 |
193 |
$5K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
251 |
246 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
393 |
355 |
$4K |
| 94760 |
|
2,389 |
2,120 |
$3K |
| 99188 |
|
88 |
80 |
$2K |
| 90686 |
|
4,363 |
4,244 |
$2K |
| 36416 |
|
428 |
408 |
$1K |
| 99174 |
|
69 |
65 |
$1K |
| 99177 |
|
62 |
59 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
54 |
52 |
$978.77 |
| 96160 |
|
44 |
39 |
$820.65 |
| D0145 |
Oral evaluation for a patient under three years of age |
29 |
26 |
$806.00 |
| D1206 |
Topical application of fluoride varnish |
13 |
13 |
$322.40 |
| 83655 |
|
14 |
13 |
$150.28 |
| 92551 |
|
14 |
14 |
$90.86 |
| 85018 |
|
1,525 |
1,449 |
$76.84 |
| 90656 |
|
334 |
320 |
$22.35 |
| 3008F |
|
4,311 |
4,202 |
$0.00 |
| 90723 |
|
26 |
24 |
$0.00 |
| 90680 |
|
14 |
12 |
$0.00 |
| 90647 |
|
12 |
12 |
$0.00 |
| 99000 |
|
14 |
14 |
$0.00 |
| 90461 |
|
1,465 |
1,284 |
$0.00 |
| 99072 |
|
1,765 |
1,689 |
$0.00 |
| 90670 |
|
95 |
91 |
$0.00 |